Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis

Liu,Ming-Wei; Wang,Yun-Hui; Qian,Chuan-Yun; Li,Hui

doi:10.3892/ijmm.2014.1943

Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis

Authors:
- Ming-Wei Liu
- Yun-Hui Wang
- Chuan-Yun Qian
- Hui Li
View Affiliations

Affiliations: Department of Emergency, The First Hospital Affiliated To Kunming Medical University, Kunming, Yunnan 650000, P.R. China, Surgical Intensive Care Unit, The Second Hospital Affiliated To Kunming Medical University, Kunming, Yunnan 650000, P.R. China
Published online on: September 23, 2014 https://doi.org/10.3892/ijmm.2014.1943
Pages: 1492-1504
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Xuebijing (XBJ) is a type of traditional Tibetan medicine, and previous pharmacological studies have shown that the ethanol extract is derived from Chuanxiong, Chishao, Danshen and Honghua. Chuanxiong, Chishao, Danshen and Honghua possesses potent anti-inflammatory activity, and has been used in the treatment of inflammatory infectious diseases. In the present study, we investigated the effects of XBJ on pulmonary permeability and lung injury in cecal ligation and puncture (CLP)‑induced sepsis in rats. A CLP sepsis model was established for the control and treatment groups, respectively. Approximately 2 h prior to surgery, an amount of 100 mg/kg XBJ injection was administered to the treatment group. Reverse transcription polymerase chain reaction (PT-PCR) and western blot analysis were used to examine the expression of Toll‑interacting protein (Tollip), interleukin-1 receptor-associated kinase 1 (IRAK1), Toll-like receptor 4 (TLR4), nuclear factor-κB65 (NF-κB65) and TNF receptor‑associated factor 6 (TRAF6) in lung tissue. ELISA was applied to detect changes of tumor necrosis factor-α (TNF‑α), interleukin-6 (IL-6), interleukin-1 (IL-1), interleukin-4 (IL-4) and interleukin-10 (IL-10) levels in bronchoalveolar lavage (BAL) fluid, and intercellular adhesion molecule 1 (ICAM-1) and von willebrand factor (vWF) in serum. The number of neutrophils, albumin and total cells in the BAL fluid were measured. For histological analysis, hematoxylin and eosin (H&E) stains were evaluated. Lung permeability, the wet/dry weight ratio (W/D) and the lung pathology score were determined following the induction of ALI by CLP for 24 h. The results demonstrated that XBJ upregulated Tollip expression and blocked the activity of IRAK1, TLR4, NF-κβ65 and TRAF6. Additionally, the number of neutrophils and total cells were significantly decreased in the XBJ group compared to that in the control group. Lung permeability, the wet/dry weight ratio (W/D) and the lung pathology score were significantly decreased in the XBJ group. The histological results also demonstrated the attenuation effect of XBJ on CLP-induced lung inflammation. The results of the present study indicated that XBJ has a significantly reduced CLP-induced lung permeability by upregulating Tollip expression. The protective effects of XBJ suggest its therapeutic potential in CLP‑induced acute lung injury treatment.

View Figures

View References

1	Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000. View Article : Google Scholar : PubMed/NCBI
2	Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005. View Article : Google Scholar : PubMed/NCBI
3	Berthiaume Y, Folkesson HG and Matthay MA: Lung edema clearance: 20 years of progress invited review: alveolar edema fluid clearance in the injured lung. J Appl Physiol. 93:2207–2213. 2002.PubMed/NCBI
4	Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J and Volpe F: Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol. 2:346–351. 2000. View Article : Google Scholar : PubMed/NCBI
5	Yamakami M and Yokosawa H: Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathways. Biol Pharm Bull. 27:564–566. 2004. View Article : Google Scholar : PubMed/NCBI
6	Yamakami M, Yoshimori T and Yokosawa H: Tom1, a VHS domain containing protein, interacts with Tollip, ubiquitin, and clathrin. J Biol Chem. 278:52865–52872. 2003. View Article : Google Scholar : PubMed/NCBI
7	Katoh Y, Shiba Y, Mitsuhashi H, Yanagida Y, Takatsu H and Nakayama K: Tollip and Tom1 form a complex and recruit ubiquitin conjugated proteins onto early endosomes. J Biol Chem. 279:24435–24443. 2004. View Article : Google Scholar : PubMed/NCBI
8	Brissoni B, Agostini L, Kropf M, Martinon F, Swoboda Vl, et al: Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr Biol. 16:2265–2270. 2006. View Article : Google Scholar : PubMed/NCBI
9	Zhang G and Ghosh S: Negative regulation of Toll-like receptor mediated signaling by Tollip. J Biol Chem. 277:7059–7065. 2002. View Article : Google Scholar : PubMed/NCBI
10	Capelluto DG: Tollip: a multitasking protein in innate immunity and protein trafficking. Microbes Infect. 14:140–147. 2012. View Article : Google Scholar : PubMed/NCBI
11	Sugi Y, Takahashi K, Nakano K, Hosono A and Kaminogawa S: Transcription of the Tollip gene is elevated in intestinal epithelial cells through impaired O-GlcNAcylation-dependent nuclear translocation of the negative regulator Elf-1. Biochem Biophys Res Commun. 412:704–709. 2011. View Article : Google Scholar
12	Sun ML, Ma DH, Liu M, Yu YX, Cao DB, Ma C, Wang X and Liu XL: Successful treatment of paraquat poisoning by Xuebijing, an injection concocted from multiple Chinese medicinal herbs: a case report. J Altern Complement Med. 15:1375–1378. 2009. View Article : Google Scholar : PubMed/NCBI
13	Celik S, Erdogan S and Tuzcu M: Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol Res. 60:270–276. 2009. View Article : Google Scholar
14	Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem. 193:265–275. 1951.PubMed/NCBI
15	Kakkar P, Das B and Viswanathan PN: A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 21:130–132. 1984.PubMed/NCBI
16	Rokicki W, Zalejska-Fiolka J, Mrukwa-Kominek E, Majewski W and Birkner E: Effect of selected dietary compounds on extracellular superoxide dismutase in the vitreous of chinchillas. Ophthalmic Res. 50:54–58. 2013. View Article : Google Scholar : PubMed/NCBI
17	von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, Kielstein JT, Maas R, Schmidt-Haupt R, Pekarova M, Hellwinkel O, Tsikas D, D’Alecy LG, Lau D, Willems S, Kubala L, Ehmke H, Meinertz T, Blankenberg S, Schwedhelm E, Gadegbeku CA, Böger RH, Baldus S and Sydow K: Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation. 124:2735–2745. 2011.
18	Zhang B, Liu ZY, Li YY, Luo Y, Liu ML, Dong HY, Wang YX, Liu Y, Zhao PT, Jin FG and Li ZC: Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci. 44:573–579. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zhang L, Luo N, Liu J, Duan Z, Du G, Cheng J, Lin H and Li Z: Emulsified isoflurane preconditioning protects against liver and lung injury in rat model of hemorrhagic shock. J Surg Res. 171:783–790. 2011. View Article : Google Scholar : PubMed/NCBI
20	Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW and Crystal RG: Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 120:893–899. 1979.PubMed/NCBI
21	Risøe PK, Ryg U, Wang YY, Rutkovskiy A, Smedsrød B, Valen G and Dahle MK: Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR142–3p. Shock. 36:390–395. 2011.PubMed/NCBI
22	Li HF, Sun MG, Yu YX and Liu XL: Xuebijing alters tumor necrosis factor-alpha, interleukin-1beta and p38 mitogen activated protein kinase content in a rat model of cardiac arrest following cardiopulmonary resuscitation. Neural Regen Res. 6:2573–2576. 2011.
23	Chen Y, Tong HS, Zhang XQ, Tang LQ, Pan ZG, Liu ZF, Duan PK and Su L: Xuebijing injection alleviates liver injury by inhibiting secretory function of Kupffer cells in heat stroke rats. J Tradit Chin Med. 33:243–249. 2013. View Article : Google Scholar : PubMed/NCBI
24	Qi F, Liang ZX, She DY, Yan GT and Chen LA: A clinical study on the effects and mechanism of xuebijing injection in severe pneumonia patients. J Tradit Chin Med. 31:46–49. 2011. View Article : Google Scholar : PubMed/NCBI
25	Shao M, Liu B, Wang JQ, Tao XG, Zhou SS, Jin K and Zhang CP: Effect of Xuebijing injection on T helper 17 and CD4⁺ CD25⁺ regulatory T cells in patients with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:430–434. 2011.(In Chinese).
26	Sun J, Xue Q, Guo L, Cui L and Wang J: Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits. Exp Lung Res. 36:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
27	Zhou G, Kamenos G, Pendem S, Wilson JX and Wu F: Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am J Physiol Regul Integr Comp Physiol. 302:R409–R416. 2012. View Article : Google Scholar : PubMed/NCBI
28	Nan YH, Park IS, Hahm KS and Shin SY: Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. J Pept Sci. 17:812–817. 2011. View Article : Google Scholar : PubMed/NCBI
29	Hukkanen RR, Liggitt HD, Murnane RD and Frevert CW: Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation. Toxicol Pathol. 37:799–804. 2009. View Article : Google Scholar
30	Moncada-Pazos A, Obaya AJ, Llamazares M, Heljasvaara R, Suárez MF, Colado E, Noël A, Cal S and López-Otín C: ADAMTS-12 metalloprotease is necessary for normal inflammatory response. J Biol Chem. 287:39554–39563. 2012. View Article : Google Scholar : PubMed/NCBI
31	Ghosh S and Hayden MS: Newregulators of NF-κB in inflammation. Nat Rev Immunol. 8:837–848. 2008.
32	Zhao D, Ding R, Mao Y, Wang L, Zhang Z and Ma X: Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses. Inflammation. 35:1825–1832. 2012. View Article : Google Scholar : PubMed/NCBI
33	Ji MH, Zhu XL, Liu FF, Li GM, Tian M, Wu J, Fan YX, Li N and Yang JJ: Alpha 2A-adrenoreceptor blockade improves sepsis-induced acute lung injury accompanied with depressed high mobility group box-1 levels in rats. Cytokine. 60:639–645. 2012. View Article : Google Scholar : PubMed/NCBI
34	Li X, Zheng Z, Li X and Ma X: Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell. Cytokine. 60:114–121. 2012.PubMed/NCBI
35	Biswas A, Wilmanski J, Forsman H, Hrncir T, Hao L, Tlaskalova-Hogenova H and Kobayashi KS: Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol. 41:182–194. 2011. View Article : Google Scholar : PubMed/NCBI
36	Ostuni R, Zanoni I and Granucci F: Deciphering the complexity of Toll-like receptor signaling. Cell Mol Life Sci. 67:4109–4134. 2010. View Article : Google Scholar : PubMed/NCBI
37	Liew FY, Xu D, Brint EK and O’Neill LA: Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 5:446–458. 2005. View Article : Google Scholar : PubMed/NCBI
38	Oshima N, Ishihara S, Rumi MAK, Aziz MM, Mishima Y, Kadota C, Moriyama I, Ishimura N, Amano Y and Kinoshita Y: A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol. 159:185–198. 2010. View Article : Google Scholar : PubMed/NCBI
39	Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR and Li X: SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 4:920–927. 2003. View Article : Google Scholar : PubMed/NCBI
40	Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R and Flavell RA: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:191–202. 2002. View Article : Google Scholar : PubMed/NCBI
41	Bulut Y, Faure E, Thomas L, Equils O and Arditi M: Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein a lipoprotein: role of toll interacting protein and IL-1 receptor signaling molecules in toll-like receptor 2 signaling. J Immunol. 167:987–994. 2001.PubMed/NCBI
42	Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R and Tschopp J: Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med. 197:263–268. 2003. View Article : Google Scholar : PubMed/NCBI
43	Neumann D, Lienenklaus S, Rosati O and Martin MU: IL-1β-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1. Eur J Immunol. 32:3689–3698. 2002.
44	Shimizu K, Taniyama Y, Sanada F, Azuma J, Iwabayashi M, Iekushi K, Rakugi H and Morishita R: Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation. Arterioscler Thromb Vasc Biol. 32:2687–2693. 2012. View Article : Google Scholar
45	Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, Roberts LJ, Dworski R, Mackman N and Ware LB: Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax. 67:1032–1039. 2012. View Article : Google Scholar : PubMed/NCBI
46	Bedirli N, Demirtas CY, Akkaya T, Salman B, Alper M, Bedirli A and Pasaoglu H: Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. J Surg Res. 178:e17–e23. 2012. View Article : Google Scholar : PubMed/NCBI
47	Yageta Y, Ishii Y, Morishima Y, Masuko H, Ano S, Yamadori T, Itoh K, Takeuchi K, Yamamoto M and Hizawa N: Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol. 85:4679–4690. 2011. View Article : Google Scholar : PubMed/NCBI
48	Boutten A, Goven D, Boczkowski J and Bonay M: Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway. Expert Opin Ther Targets. 14:329–346. 2010. View Article : Google Scholar : PubMed/NCBI
49	Cho HY, Imani F, Miller-DeGraff L, Walters D, Melendi GA, Yamamoto M, Polack FP and Kleeberger SR: Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med. 179:138–150. 2009. View Article : Google Scholar : PubMed/NCBI
50	Jeong SJ, Han SH, Kim CO, Choi JY and Kim JM: Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care. 17:R97–R98. 2013. View Article : Google Scholar : PubMed/NCBI
51	Qiu Y, Ferguson J, Oltean S, Neal CR, Kaura A, Bevan H, Wood E, Sage LM, Lanati S, Nowak DG, Salmon AH, Bates D and Harper SJ: Overexpression of VEGF165b in podocytes reduces glomerular permeability. J Am Soc Nephrol. 21:1498–1509. 2010. View Article : Google Scholar : PubMed/NCBI
52	Jezovnik MK and Poredos P: Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol. 29:226–231. 2010.PubMed/NCBI
53	Hack CE and Zeerleder S: The endothelium in sepsis: source of and a target for inflammation. Crit Care Med. 29:S21–S27. 2001.PubMed/NCBI
54	Reinhart K, Bayer O, Brunkhorst F and Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 30:S302–S312. 2002. View Article : Google Scholar : PubMed/NCBI
55	Lucas R, Sridhar S, Rick FG, Gorshkov B, Umapathy NS, Yang G, Oseghale A, Verin AD, Chakraborty T, Matthay MA, Zemskov EA, White R, Block NL and Schally AV: Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Am J Physiol Renal Physiol. 303:F1026–F1036. 2012.PubMed/NCBI